119 related articles for article (PubMed ID: 36089748)
21. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
Zhang X; Zhong JL; Liu W; Gao Z; Xue X; Yue P; Wang L; Zhao C; Xu W; Qu X
Cancer Chemother Pharmacol; 2010 May; 66(1):11-9. PubMed ID: 19756602
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2, uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane tubulation.
Shinotsuka C; Yoshida Y; Kawamoto K; Takatsu H; Nakayama K
J Biol Chem; 2002 Mar; 277(11):9468-73. PubMed ID: 11777925
[TBL] [Abstract][Full Text] [Related]
23. 9-Nitro-20(S)-carbonate-camptothecin (NCP4), a novel prodrug of 9-nitrocamptothecin (9-NC), exhibits potent chemotherapeutic efficacy and improved safety against hepatocarcinoma.
Zhou H; Zhang Y; Tian Y; Sun Y; Chen Y; Zhang Y; Zhu Q; Pan J; Qing C
Eur J Pharmacol; 2022 May; 923():174898. PubMed ID: 35305999
[TBL] [Abstract][Full Text] [Related]
24. Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt-regulated autophagy.
Zhou L; Gao W; Wang K; Huang Z; Zhang L; Zhang Z; Zhou J; Nice EC; Huang C
FASEB J; 2019 Apr; 33(4):5520-5534. PubMed ID: 30668917
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs.
Liu H; Wang YJ; Yang L; Zhou M; Jin MW; Xiao GS; Wang Y; Sun HY; Li GR
Sci Rep; 2016 May; 6():25743. PubMed ID: 27160397
[TBL] [Abstract][Full Text] [Related]
27. Mislocalization of large ARF-GEFs as a potential mechanism for BFA resistance in COG-deficient cells.
Flanagan-Steet H; Johnson S; Smith RD; Bangiyeva J; Lupashin V; Steet R
Exp Cell Res; 2011 Oct; 317(16):2342-52. PubMed ID: 21722633
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of the brefeldin A analogue (6R)-hydroxy-BFA in tobacco and Arabidopsis.
Langhans M; Förster S; Helmchen G; Robinson DG
J Exp Bot; 2011 May; 62(8):2949-57. PubMed ID: 21357769
[TBL] [Abstract][Full Text] [Related]
29. Recent Synthesis and Discovery of Brefeldin A Analogs.
Paek SM
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29670019
[TBL] [Abstract][Full Text] [Related]
30. Nitroarylmethylcarbamate prodrugs of doxorubicin for use with nitroreductase gene-directed enzyme prodrug therapy.
Hay MP; Wilson WR; Denny WA
Bioorg Med Chem; 2005 Jun; 13(12):4043-55. PubMed ID: 15911317
[TBL] [Abstract][Full Text] [Related]
31. The integrity of the plant Golgi apparatus depends on cell growth-controlled activity of GNL1.
Du W; Tamura K; Stefano G; Brandizzi F
Mol Plant; 2013 May; 6(3):905-15. PubMed ID: 23125314
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus replication and Golgi function in brefeldin a-resistant hepatoma-derived cells.
Farhat R; Goueslain L; Wychowski C; Belouzard S; Fénéant L; Jackson CL; Dubuisson J; Rouillé Y
PLoS One; 2013; 8(9):e74491. PubMed ID: 24058576
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs.
Chen J; Du W
Med Chem; 2013 Aug; 9(5):740-7. PubMed ID: 23061567
[TBL] [Abstract][Full Text] [Related]
34. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
[TBL] [Abstract][Full Text] [Related]
35. A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts.
Endo M; Miwa M; Ura M; Tanimura H; Taniguchi K; Miyazaki Y; Ohwada J; Tsukazaki M; Niizuma S; Murata T; Ozawa S; Suda H; Ogawa K; Nanba E; Nagao S; Shimma N; Yamada-Okabe H
Cancer Chemother Pharmacol; 2010 Jan; 65(2):363-71. PubMed ID: 19495753
[TBL] [Abstract][Full Text] [Related]
36. Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
Cai ZW; Zhang Y; Borzilleri RM; Qian L; Barbosa S; Wei D; Zheng X; Wu L; Fan J; Shi Z; Wautlet BS; Mortillo S; Jeyaseelan R; Kukral DW; Kamath A; Marathe P; D'Arienzo C; Derbin G; Barrish JC; Robl JA; Hunt JT; Lombardo LJ; Fargnoli J; Bhide RS
J Med Chem; 2008 Mar; 51(6):1976-80. PubMed ID: 18288793
[TBL] [Abstract][Full Text] [Related]
37. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
38. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics.
Haider S; Penfornis P; Claudio PP; McChesney JD; Chittiboyina AG
Eur J Med Chem; 2022 Jan; 227():113891. PubMed ID: 34656042
[TBL] [Abstract][Full Text] [Related]
39. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
40. Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds.
Greenwald RB; Pendri A; Conover CD; Zhao H; Choe YH; Martinez A; Shum K; Guan S
J Med Chem; 1999 Sep; 42(18):3657-67. PubMed ID: 10479297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
